Latest Biologic Stories
Moderna venture to advance mRNA vaccines and mRNA-based passive immunity therapies CAMBRIDGE, Mass., Jan.
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
LONDON, Jan. 7, 2015 /PRNewswire/ -- About Psoriasis and Its TypesPsoriasis is a common immune-mediated disease of the skin.
ROCKVILLE, Md., Jan.
CAMBRIDGE, England, January 6, 2015 /PRNewswire/ -- Crescendo Biologics, a company focused on the discovery and development of best-in-class Humabody(TM) human VH antibody
Represents a Novel Approach to Treating B-cell Lymphoma in Dogs KANSAS CITY, Kan., Jan.
Additional Management Appointments Mark Company Progress SOUTH SAN FRANCISCO, Jan.
-- On Schedule to Release Topline Data from Phase 1b Clinical Trial and to Start Phase 2 Clinical Trial of SYN-004 in 1Q 2015 -- ROCKVILLE, Md., Dec.
- A young chicken: also used as a pet name for children.